Quality Attribute Considerations for Chewable Tablets Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
August 21, 2018
April 14, 2020
04e1f98a-29f4-4cc9-a0ab-4017b9877ce9
Related Documents
Botanical Drug Development: Guidance for Industry
Guidance DocumentDecember 29, 2016Center for Drug Evaluation and Research
Immunogenicity-Related Considerations for Low Molecular Weight Heparin Guidance for Industry
Guidance DocumentFebruary 18, 2016Center for Drug Evaluation and Research
Regulatory Classification of Pharmaceutical Co-Crystals
Guidance DocumentFebruary 15, 2018Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox